Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Ryan T Nitta"'
Autor:
Suzana Assad Kahn, Silvia Lima Costa, Sharareh Gholamin, Ryan T Nitta, Luiz Gustavo Dubois, Marie Fève, Maria Zeniou, Paulo Lucas Cerqueira Coelho, Elias El‐Habr, Josette Cadusseau, Pascale Varlet, Siddhartha S Mitra, Bertrand Devaux, Marie‐Claude Kilhoffer, Samuel H Cheshier, Vivaldo Moura‐Neto, Jacques Haiech, Marie‐Pierre Junier, Hervé Chneiweiss
Publikováno v:
EMBO Molecular Medicine, Vol 8, Iss 5, Pp 511-526 (2016)
Abstract A variety of drugs targeting monoamine receptors are routinely used in human pharmacology. We assessed the effect of these drugs on the viability of tumor‐initiating cells isolated from patients with glioblastoma. Among the drugs targeting
Externí odkaz:
https://doaj.org/article/e0c2de418b164543ac5b7d7885f022cd
Publikováno v:
PLoS ONE, Vol 2, Iss 9, p e963 (2007)
A-type lamins, predominantly lamins A and C, are nuclear intermediate filaments believed to act as scaffolds for assembly of transcription factors. Lamin A/C is necessary for the retinoblastoma protein (pRB) stabilization through unknown mechanism(s)
Externí odkaz:
https://doaj.org/article/f355bb363f8d484ca01617e9a0f10ddc
Autor:
Suzana A. Kahn, Xin Wang, Ryan T. Nitta, Sharareh Gholamin, Johanna Theruvath, Gregor Hutter, Tej D. Azad, Lina Wadi, Sara Bolin, Vijay Ramaswamy, Rogelio Esparza, Kun-Wei Liu, Michael Edwards, Fredrik J. Swartling, Debashis Sahoo, Gordon Li, Robert J. Wechsler-Reya, Jüri Reimand, Yoon-Jae Cho, Michael D. Taylor, Irving L. Weissman, Siddhartha S. Mitra, Samuel H. Cheshier
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-9 (2018)
Group 3 medulloblastoma is an aggressive pediatric brain tumour that disseminates through the leptomeningeal cerebral spinal fluid. Here, the authors show that in Group 3 medulloblastoma NOTCH1 activates BMI1 through the activation of TWIST1, driving
Externí odkaz:
https://doaj.org/article/f343b2e492454377a5d248f3fe9493fb
Publikováno v:
Journal of Neurosurgery: Pediatrics. 30:555-566
OBJECTIVE Medulloblastoma (MB) is the most common malignant pediatric brain tumor and accounts for approximately 20% of all pediatric CNS tumors. Current multimodal treatment is associated with a 70%–90% 5-year survival rate; however, the prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd299a9680a1b121248e31bdf27e8687
https://doi.org/10.3171/2022.8.peds22300
https://doi.org/10.3171/2022.8.peds22300
Autor:
Albert J. Wong, Craig P. Giacomini, A. Hunter Shain, Ryan T. Nitta, Kristin C. Jensen, Catherine A. Del Vecchio
PDF file - 1.2MB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::713ce55531559daa50a8e6a945a695ae
https://doi.org/10.1158/0008-5472.22390353.v1
https://doi.org/10.1158/0008-5472.22390353.v1
Autor:
Albert J. Wong, Craig P. Giacomini, A. Hunter Shain, Ryan T. Nitta, Kristin C. Jensen, Catherine A. Del Vecchio
PDF file - 1.3MB
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57da9d16503d46ddca91d103f29fcf13
https://doi.org/10.1158/0008-5472.22390347.v1
https://doi.org/10.1158/0008-5472.22390347.v1
Autor:
Albert J. Wong, Craig P. Giacomini, A. Hunter Shain, Ryan T. Nitta, Kristin C. Jensen, Catherine A. Del Vecchio
EGFRvIII is a tumor-specific variant of the epidermal growth factor receptor (EGFR). Although EGFRvIII is most commonly found in glioblastoma, its expression in other tumor types remains controversial. In this study, we investigated EGFRvIII expressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f70c583e480b195bf8c7751d0137d11
https://doi.org/10.1158/0008-5472.c.6502917.v1
https://doi.org/10.1158/0008-5472.c.6502917.v1